is glp 1 and tirzepatide the same Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs Semaglutide vs Tirzepatide for Weight

It suggests elevated fasting insulin and higher HOMA-IR may indicate greater potential benefit, that higher inflammatory markers may improve with treatment, and that a lower estradiol level mainly signals menopause phase and helps set realistic expectations rather than predicting the size of any weight change

Current UK clinical guidance does not support berberine as a substitute for evidence-based diabetes treatments

While encouraging, these findings underscore the need for personalized medical advice and monitoring when considering semaglutide as part of a treatment plan

address/contact from the products FDA label